Baran Seven | Molecular Biology | Best Researcher Award

Dr. Baran Seven | Molecular Biology | Best Researcher Award

Researcher in Biotechnology from TST Fittings and Medical Devices Industry and Trade Ltd Co | Turkey

Dr. Baran Seven is a highly dedicated and accomplished researcher in the field of Biology, with a specialization in toxicology, genotoxicology, and environmental biology. He holds a Ph.D. from Giresun University and has devoted his academic career to exploring the physiological, genetic, and biochemical impacts of various toxic agents using experimental models such as albino mice and Allium cepa root tips. His research is particularly focused on understanding the damage caused by environmental pollutants like cypermethrin, parabens, and heavy metals, as well as investigating the protective roles of natural substances such as Urtica dioica and Nigella sativa. Dr. Seven has been involved in numerous national research projects and has published extensively in both national and international journals, including Scientific Reports and Global NEST. He has presented his work at significant scientific conferences, demonstrating his commitment to knowledge dissemination and academic engagement. With a strong background in experimental toxicology and molecular biology, he continues to contribute meaningful insights to the understanding of environmental health risks. His work is relevant to public health, food safety, and environmental protection, making him a valuable asset to the academic and scientific community in Turkey and beyond.

Professional Profile

Education

Dr. Baran Seven’s academic journey began with a Bachelor’s degree in Biology from Giresun University in 2013. He continued his education in the same institution, completing a Master’s degree in 2015 under the Department of Biology. His MSc thesis explored the protective effects of Urtica dioica (nettle extract) against paraben-induced toxicity in albino mice, under the supervision of Assoc. Prof. Dr. Kültiğin Çavuşoğlu and Prof. Dr. Kürşad Yapar. This early research laid the foundation for his long-term interest in natural protectants against environmental toxins. In 2022, Dr. Seven earned his Ph.D. in Biology from Giresun University. His doctoral thesis, supervised by Prof. Dr. Kültiğin Çavuşoğlu, was titled “Investigation of Cypermethrin Toxicity in Swiss Albino Mice: A Physiological, Genetic and Biochemical Approach.” This work involved the use of sophisticated assays to analyze the effects of cypermethrin, a widely used pesticide, highlighting his expertise in interdisciplinary methods. Throughout his academic career, Dr. Seven has displayed consistent scholarly growth, choosing thesis topics that reflect emerging concerns in toxicology and environmental biology. His education has equipped him with both theoretical knowledge and practical research skills in molecular, biochemical, and physiological domains of biology.

Professional Experience

Dr. Baran Seven has accumulated substantial professional experience as a biologist and academic researcher. Throughout his academic trajectory at Giresun University, he has contributed to various scientific investigations and served as a research assistant or contributing scientist in several funded projects. His roles have included conducting laboratory experiments, analyzing toxicological effects, and validating findings using established molecular and biochemical protocols. Among the research projects he contributed to are investigations on the physiological and genotoxic effects of ultraviolet radiation on Allium cepa root tip cells and the protective roles of compounds like carotene and black seed (Nigella sativa) against lead and ammonium sulfate-induced toxicity. He has taken part in both experimental design and data interpretation phases, demonstrating his comprehensive involvement. Dr. Seven’s conference participation also speaks to his professional engagement, as he has presented findings at multiple international and national scientific gatherings. These experiences have enabled him to collaborate with academic peers, refine his methodologies, and gain valuable insights into global environmental health issues. His continuing research and scholarly output reflect an integrated and expanding professional portfolio grounded in experimental toxicology, environmental biology, and molecular diagnostics.

Research Interest

Dr. Baran Seven’s research interests are centered on toxicology, genotoxicity, oxidative stress mechanisms, and the application of natural extracts for therapeutic purposes. He is particularly interested in understanding how environmental pollutants such as pesticides (e.g., cypermethrin), industrial chemicals (e.g., parabens), and heavy metals (e.g., lead, lithium, titanium dioxide) interact with living organisms at the genetic, cellular, and systemic levels. His work employs both in vivo models (notably albino mice) and plant-based systems (e.g., Allium cepa) to evaluate toxicity and its potential reversal using natural antioxidants. He investigates DNA damage using comet assays, chromosomal aberration tests, and other molecular techniques. A key area of his interest lies in evaluating the protective roles of natural substances, such as grape seed extract, green coffee, resveratrol, and Nigella sativa, against genotoxic stress. His aim is to identify safe, plant-based therapeutic alternatives for mitigating the harmful effects of various chemicals. His interdisciplinary approach combines biology, toxicology, pharmacology, and environmental science. This holistic research focus places Dr. Seven at the intersection of molecular biology and public health, addressing urgent concerns about food safety, environmental contamination, and sustainable chemical use.

Research Skills

Dr. Baran Seven possesses a well-developed skill set in molecular biology, toxicological assays, and biochemical analysis. He is proficient in various experimental techniques such as the comet assay for DNA damage detection, chromosomal aberration analysis, and micronucleus formation assays. These tools enable him to examine genotoxic effects at a molecular level. Additionally, he has expertise in biochemical assays to measure oxidative stress parameters, including enzymatic activity (e.g., catalase, SOD) and lipid peroxidation. His training also includes physiological assessments in model organisms like mice, evaluating weight change, organ histology, and behavioral responses to toxins. Dr. Seven is also skilled in plant-based bioassays, particularly using Allium cepa root tips to assess genotoxicity in environmental samples or chemical treatments. His data analysis capabilities include statistical evaluation using SPSS or similar platforms, and he is experienced in writing technical reports and scientific articles for peer-reviewed journals. He has also demonstrated his capabilities in research project planning and implementation, often collaborating with fellow researchers and supervisors to develop effective methodologies. His cumulative skill set makes him highly competent in conducting both laboratory-based and applied research in toxicology and environmental health.

Awards and Honors

While specific awards or honors are not explicitly listed, Dr. Baran Seven’s extensive contributions to nationally funded research projects, his publication in Scientific Reports (Nature group), and frequent conference presentations serve as significant academic distinctions. His active participation in over a dozen high-level scientific congresses and symposia—including IBCESS, Ecology Symposia, and Balkan International Applied Sciences Congress—highlights his continued recognition within the scientific community. He has also consistently collaborated with respected researchers such as Prof. Dr. Kültiğin Çavuşoğlu and has served as a lead or co-author in multiple peer-reviewed journals. His works have been published in high-impact platforms such as Global NEST Journal, Scientific Reports, and several Turkish Science Journals indexed in national databases. Presenting full-text studies at national and international congresses demonstrates not only his academic excellence but also his ability to communicate complex findings effectively to the scientific public. These achievements are indicative of an emerging academic with the potential for future honors, research fellowships, or international project leadership roles.

Publications Top Notes

  1. Investigation of cypermethrin toxicity in Swiss albino mice with physiological, genetic and biochemical approaches
  • Year: 2022

  • Citations: 25

Conclusion

Dr. Baran Seven is a committed and impactful researcher whose work bridges the fields of molecular toxicology, environmental health, and pharmacological protection. His contributions to understanding the physiological and genetic impact of chemical exposure—combined with his work on plant-based therapeutic interventions—underscore his value to both academia and public health. With more than 20 publications and numerous national research engagements, Dr. Seven has demonstrated both productivity and purpose in his scholarly journey. His commitment to environmentally safe science and health risk mitigation aligns with global research priorities, especially regarding sustainable living and food safety. With further global exposure and increased international collaboration, Dr. Seven is poised to emerge as a future leader in biological sciences and toxicology research. He is undoubtedly a deserving candidate for recognition under the International Research Awards, with a solid track record and clear potential for greater achievements.

Shane Scott | Molecular Biology | Best Researcher Award

Dr. Shane Scott | Molecular Biology | Best Researcher Award

Medical Student from The Ohio State College of Medicine, United States

Dr. Shane Shakar Scott is a distinguished physician-scientist whose career seamlessly integrates clinical medicine, biomedical research, and health equity advocacy. Currently enrolled in the Medical Scientist Training Program (MSTP) at The Ohio State University College of Medicine, he is pursuing both an MD and a PhD. His doctoral research focuses on the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure, contributing significantly to the field of cardio-oncology. Dr. Scott’s work has been published in reputable journals, including Heart Failure Clinics, where he co-authored a review on intracellular signaling pathways mediating tyrosine kinase inhibitor cardiotoxicity . Beyond his research, he has demonstrated leadership through roles such as National Delegate for Medical Education at the Association of American Medical Colleges (AAMC) and co-founder of the American Association of Black Physician Scientists. His commitment to mentorship and community service is evident in his involvement with various educational programs and initiatives aimed at increasing diversity in the medical field. Dr. Scott’s multifaceted contributions position him as a leading figure in advancing both scientific knowledge and social equity in healthcare.

Professional Profile

Education

Dr. Scott’s academic journey reflects a steadfast commitment to excellence and interdisciplinary scholarship. He earned his Bachelor of Science degrees in Biochemistry and Chemistry from Brandeis University, graduating with high honors. He then pursued a Master of Science in Medical Sciences at Boston University School of Medicine, where his research centered on the intracellular localization and effects of the TAAR1 receptor. Currently, Dr. Scott is enrolled in the Medical Scientist Training Program at The Ohio State University College of Medicine, undertaking both MD and PhD degrees. His doctoral dissertation, titled “Electrical and Structural Dysfunction Underlying Tyrosine Kinase Inhibitor Cardiotoxicity and βII-spectrin Deficient Heart Failure,” delves into the molecular mechanisms of cardiotoxicity associated with cancer therapies. This rigorous academic foundation equips Dr. Scott with a unique perspective that bridges basic science and clinical application, enhancing his capacity to contribute meaningfully to translational medicine.

Professional Experience

Dr. Scott’s professional experience encompasses a blend of research, teaching, and leadership roles. As a graduate trainee at the Davis Heart and Lung Research Institute, he investigated the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure. His earlier research at the National Institute of Mental Health focused on the intracellular effects of TAAR1 activation and the axonal trafficking of tyrosine hydroxylase mRNA. In addition to his research endeavors, Dr. Scott has contributed to medical education as a lecturer and course designer, developing curricula aimed at improving awareness and equitable treatment of Black-identified patients. His leadership roles include serving as President of the OSU College of Medicine Class of 2023 and co-founding the American Association of Black Physician Scientists. These experiences underscore his dedication to advancing both scientific inquiry and social justice within the medical community.

Research Interests

Dr. Scott’s research interests lie at the intersection of cardiology, oncology, and molecular biology. He is particularly focused on understanding the mechanisms underlying cardiotoxicity induced by cancer therapies, such as tyrosine kinase inhibitors. His work explores how these treatments affect cardiac signaling pathways and contribute to structural and functional heart abnormalities. Additionally, Dr. Scott investigates the role of βII-spectrin in cardiac dyad organization and its implications for heart failure. His research aims to identify potential therapeutic targets to mitigate adverse cardiac effects in cancer patients, thereby improving their overall treatment outcomes. Through his studies, Dr. Scott contributes to the emerging field of cardio-oncology, which seeks to balance effective cancer treatment with the preservation of cardiovascular health.

Research Skills

Dr. Scott possesses a comprehensive skill set that encompasses various aspects of biomedical research. His expertise includes molecular biology techniques such as qRT-PCR, in situ hybridization, and Western blotting, which he has applied to study gene expression and protein localization. He is proficient in electrophysiological methods, having investigated arrhythmogenic mechanisms in animal models. Dr. Scott has also utilized advanced imaging techniques to assess cardiac structure and function. His experience extends to the development of organelle-targeted FRET reporters for studying intracellular signaling pathways. Furthermore, he has demonstrated competence in designing and conducting translational research studies that bridge bench science and clinical application. These skills enable Dr. Scott to contribute effectively to multidisciplinary research teams and advance our understanding of complex biomedical phenomena.

Awards and Honors

Dr. Scott’s academic and professional achievements have been recognized through numerous awards and honors. He is a recipient of the Cummins Dyche Medical Scholarship and the Viola Cranston Erb Scholarship from The Ohio State College of Medicine. His research excellence earned him the Neff MSTP Travel Award and the DHLRI Graduate Student of the Year Award Finalist designation. Dr. Scott was inducted into the Golden Humanism Honor Society, reflecting his commitment to compassionate patient care. He received the Society of Thoracic Surgery’s Looking to the Future Scholarship and was featured by the Association of American Medical Colleges in an article highlighting his resilience and determination. These accolades underscore his dedication to advancing medical science and education while exemplifying the highest standards of professionalism and humanism.

Conclusion

Dr. Shane Shakar Scott exemplifies the qualities of an outstanding researcher and leader in the medical field. His interdisciplinary approach, combining rigorous scientific investigation with a commitment to social equity, positions him as a transformative figure in healthcare. Through his research on cardiotoxicity and heart failure, Dr. Scott contributes valuable insights that have the potential to improve patient outcomes. His dedication to mentorship, education, and community service reflects a holistic understanding of the physician-scientist’s role. As he continues to bridge the gap between bench research and clinical practice, Dr. Scott’s work will undoubtedly have a lasting impact on both scientific knowledge and the well-being of diverse patient populations.

Publications Top Notes

  1. Title: Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
    Journal: Heart Failure Clinics
    Year: 2022 (June)
    DOI: 10.1016/j.hfc.2022.02.003
    Author: Shane Shakar Scott

  2. Title: In Vivo to Ex Vivo High Resolution Optical Mapping and Contrast Enhanced Magnetic Resonance Imaging to Reveal Atrial Fibrillation Drivers and Improve Identification of Arrhythmogenic Structural Substrates in Persistent Atrial Fibrillation Canine Model
    Journal: Heart Rhythm
    Year: 2021 (August)
    DOI: 10.1016/j.hrthm.2021.06.937
    Author: Shane Shakar Scott

  3. Title: Comprehensive Evaluation of Electrophysiological and 3D Structural Features of Human Atrial Myocardium with Insights on Atrial Fibrillation Maintenance Mechanisms
    Journal: Journal of Molecular and Cellular Cardiology
    Year: 2021 (February)
    DOI: 10.1016/j.yjmcc.2020.10.012
    Author: Shane Shakar Scott

  4. Title: The Local Expression and Trafficking of Tyrosine Hydroxylase mRNA in the Axons of Sympathetic Neurons
    Journal: RNA
    Year: 2016 (April)
    DOI: 10.1261/rna.053272.115
    Authors: Noreen M. Gervasi; Shane S. Scott; Armaz Aschrafi; Jenna Gale; Sanah N. Vohra; Margaret A. MacGibeny; Amar N. Kar; Anthony E. Gioio; Barry B. Kaplan

Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Prof. Dr. Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Professor of Physiology from Institute of Laboratory Animal Sciences, China

Professor Jiang Xiaoliang is a distinguished researcher and Master’s Supervisor at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Born in March 1987, he has built an impressive career in cardiovascular research, laboratory animal sciences, and molecular mechanisms underlying hypertension and cardiac disorders. With over a decade of dedicated research, he has contributed significantly to understanding the role of epigenetic regulation, signal transduction pathways, and disease modeling. His extensive experience in both national and international institutions has led to numerous high-impact publications in prestigious journals such as Advanced Science, Hypertension, and the Journal of the American Heart Association. Additionally, he has successfully led and participated in major research projects funded by the National Natural Science Foundation of China and the Chinese Academy of Medical Sciences. Professor Jiang’s work demonstrates a seamless integration of experimental pathology, physiology, and translational medicine. His contributions have been recognized through several awards and honors, affirming his role as a leading scholar in his field. Jiang’s continuous commitment to innovation and excellence marks him as a highly suitable candidate for distinguished research awards. His profile reflects both depth and breadth of expertise, making him a role model for aspiring scientists.

Professional Profile

Education

Professor Jiang Xiaoliang has pursued a focused and prestigious educational path aligned with his research interests in pathology, physiology, and biological sciences. He obtained his Ph.D. in Pathology and Pathophysiology from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, between September 2011 and July 2014. His doctoral studies allowed him to develop an in-depth understanding of disease mechanisms at the molecular and cellular levels, particularly within the cardiovascular system. Before his Ph.D., he earned his M.S. in Physiology from the same institute between September 2009 and July 2011, further enhancing his knowledge of bodily functions and their disruptions in disease states. His academic journey began with a B.S. in Biological Science from Shandong Normal University, completed from September 2005 to July 2009. This strong foundational background equipped him with a broad knowledge of biological principles, critical thinking skills, and experimental methodologies, setting the stage for his later specialized training. Throughout his education, Professor Jiang demonstrated academic excellence and a commitment to scientific inquiry. His educational trajectory reflects a consistent dedication to advancing his expertise in biomedical sciences, perfectly positioning him for a leading role in cutting-edge medical research.

Professional Experience

Professor Jiang Xiaoliang’s professional career is deeply rooted in the Institute of Laboratory Animal Sciences at the Chinese Academy of Medical Sciences, where he has progressively advanced through academic and research roles. Currently, he serves as a Researcher since December 2024, leading key projects and supervising postgraduate research. Previously, he was an Associate Researcher from July 2018 to December 2024, where he contributed to significant research programs and established a strong reputation in cardiovascular and hypertension research. From January 2014 to July 2018, he worked as an Assistant Researcher, during which he honed his skills in experimental design, molecular biology techniques, and disease modeling. Notably, Professor Jiang also gained international experience as a Research Assistant at the University of Maryland School of Medicine, Department of Nephrology, from August 2012 to January 2014. This exposure to an international research environment broadened his perspectives and enriched his scientific approaches. Across all his roles, Professor Jiang has demonstrated outstanding leadership, technical expertise, and a passion for translational research. His career progression reflects a consistent commitment to excellence, making significant contributions to the fields of laboratory animal science and cardiovascular medicine.

Research Interests

Professor Jiang Xiaoliang’s research interests focus primarily on cardiovascular diseases, molecular and cellular mechanisms of hypertension, cardiac hypertrophy, renal physiology, and laboratory animal model development. He is particularly interested in the epigenetic regulation of cardiac reprogramming, the role of ion channels in blood pressure regulation, and the impact of neurohormonal factors on cardiovascular health. His work explores how pathways like PI3K/Akt, PKC-mediated signaling, and Na+/H+ exchangers contribute to disease pathology, and how these mechanisms can be targeted therapeutically. Additionally, he has investigated the interplay between salt sensitivity, inflammation, and oxidative stress in the development of hypertension. Another key area of his research includes the establishment and refinement of animal models for infectious and cardiovascular diseases, aiding in the development of new therapeutic interventions. His focus on translational medicine bridges basic research findings with potential clinical applications. Furthermore, Jiang has demonstrated a keen interest in the interactions between dopamine receptor pathways and cardiovascular-renal function. Through his research, he aims to uncover novel insights that can lead to innovative treatments for complex and critical diseases.

Research Skills

Professor Jiang Xiaoliang possesses an extensive array of research skills that have greatly enhanced his scientific contributions. His expertise includes molecular biology techniques such as gene editing, nucleic acid delivery, and signal transduction pathway analysis. He is proficient in developing and utilizing animal models for cardiovascular and infectious disease studies, a critical skill in translational medicine. Jiang has demonstrated advanced capabilities in histopathology, immunohistochemistry, real-time PCR, Western blotting, and other biochemical assays essential for mechanistic studies. He is highly skilled in the analysis of epigenetic modifications and their effects on gene expression, particularly concerning cardiac reprogramming and vascular biology. Additionally, his experience includes the application of pharmacological interventions and gene therapy techniques to elucidate disease pathways and therapeutic targets. Professor Jiang’s international research experience has provided him with strong data management, statistical analysis, and collaborative project management skills. His ability to design, implement, and analyze complex experiments underscores his strength in bridging basic research with clinical relevance. Through his technical proficiency and innovative approach, Jiang continues to push the boundaries of biomedical research.

Awards and Honors

Professor Jiang Xiaoliang’s outstanding contributions to science have been recognized through numerous prestigious awards and honors. In 2022, he was awarded the “Young International Award” by the Japanese Association for Laboratory Animal Science, a testament to his significant impact on the field at an early career stage. Additionally, he received the Second Prize of the Science and Technology Achievement Award from the Chinese Association for Laboratory Animals for his role in the “Creation and Application of Animal Models for Cardiovascular Diseases.” Another notable recognition was the Second Prize of the Hebei Provincial Science and Technology Progress Award in 2019, for his work on the regulation of the Renin-Angiotensin System in multiple organ injuries. Jiang was also selected for the highly competitive Youth Talent Support Project (YESS20170157) under the China Association for Life Sciences, where he secured ¥450,000 in funding for innovative research from 2017 to 2019. These honors reflect Professor Jiang’s consistent excellence, innovation, and leadership in biomedical research. His recognition by national and international bodies illustrates his important role in advancing scientific knowledge and his strong potential for future groundbreaking contributions.

Conclusion

In conclusion, Professor Jiang Xiaoliang stands out as a highly qualified and accomplished scholar in the field of biomedical sciences, particularly cardiovascular research and laboratory animal science. His educational background, combined with extensive professional experience and a strong record of research achievements, positions him as a leader and innovator in his discipline. His ability to secure competitive funding, produce high-impact publications, and contribute meaningfully to collaborative research initiatives highlights both his scientific capabilities and leadership qualities. Professor Jiang’s recognition through various prestigious awards further attests to his contributions to the advancement of science. His research exhibits a rare combination of depth, innovation, and translational relevance. Areas where he might further strengthen his profile include expanding international collaborations and leading multi-center studies to enhance global scientific impact. Overall, Professor Jiang’s impressive career trajectory, commitment to excellence, and passion for discovery make him a strong and deserving candidate for the Best Scholar Award in Research. He embodies the qualities of an outstanding researcher who continues to make significant contributions to medical science and inspire the next generation of scientists.

Publications Top Notes

  1. Title: Enpp1 Ameliorates MAFLD by Regulating Hepatocyte Lipid Metabolism Through the AMPK/PPARα Signaling Pathway

    • Authors: Liu Xiaohui, Chen Shuai, Liu Xing, Li Yuhan, Yang Zhiwei

    • Year: 2025

  2. Title: Intestinal Gastrin/CCKBR Axis Protects Against Type 2 Diabetes by Reducing Intestinal Glucose Absorption Through the PI3K/Akt/eIF4B Signaling Pathway

    • Authors: Liu Xue, Liu Xing, Liu Yunpeng, Zhang Haizeng, Yang Zhiwei

    • Year: 2025